Alternatives to Indica Labs

AI-powered digital diagnostics for anatomic and clinical pathology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Digital pathology imaging technology and AI-driven precision pathology software.

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Global life sciences company providing diagnostic and biopharma laboratory services.

Develops a computational model of the human body for drug discovery and development.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for cancer diagnostics in digital pathology.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered platform that automates drug discovery through physical AI scientists and robotic experimentation.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

AI-powered cloud quality management system for life sciences.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Biotechnology company focused on developing treatments for rare metabolic diseases.

A biotechnology company developing genetic therapies for rare disorders.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing gene editing therapies to lower cholesterol.

Develops a platform for adaptive clinical trial design and closed-loop execution.

A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

AI-powered medical imaging analysis and diagnostic support for radiologists.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.